Login to Your Account



Fun with Finances

First Quarter Shows Biotech Flailing into New Decade

By Cynthia Robbins-Roth


Tuesday, April 27, 2010
Last year saw a wonderful wave of venture cash crashing into biotech coffers. The 2009 yearend numbers were up significantly from 2008, with more deals done (57 vs. 43) and investors shoveling 38 percent more into Series A, plus 36 percent more into Series B rounds. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription